Velocity Clinical Research | Gardena, CA

Research site

Location

1141 West Redondo Beach Boulevard Suite 308, Gardena, California, United States of America

Site insights

Top conditions

Top treatments

Metformin

LY3298176

Survodutide

Tirzepatide

Orforglipron

LY3502970

ALN-HSD

Semaglutide

Sugar

Cagrilintide

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Dennis Tsang

Verified by this site

Active trials

4 of 18 total trials

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition (NASHGEN-2)

This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have Metabolic...

Enrolling

Metabolic Dysfunction-Associated SteatoHepatitis (MASH)

Drug: Placebo

Drug: ALN-HSD

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

This study is open to adults who are at least 18 years old living with obesity and have:* a confirmed liver disease called non-alcoholic steatohepati...

Enrolling

Metabolic Dysfunction Associated Steatohepatitis (MASH)

Liver Fibrosis

Combination Product: Placebo

Combination Product: Survodutide

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabet...

Enrolling

Diabetes

Type2diabetes

Device: ReCET Treatment

Device: Sham Procedure

Study of DONQ52 in Active Celiac Disease

The main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants...

Enrolling

Celiac Disease

Dietary Supplement: Simulated Inadvertent Gluten Exposure (SIGE) capsule

Drug: DONQ52